Clinical trial
New- Onset Diabetes and Glucose Regulation Are Significant Determinants of Left Ventricular Hypertrophy in Renal Transplant Recipients
NCT01976689 is registered in ClinicalTrials.gov with Baskent University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- New- Onset Diabetes and Glucose Regulation Are Significant Determinants of Left Ventricular Hypertrophy in Renal Transplant Recipients
- Lead sponsor
- Baskent University
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 31, 2012
- Completion date
- September 30, 2013
- Enrollment
- 159 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
diabetes mellitus nos new onset, hypertrophy, left ventricular, vascular stiffness